You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

annexin A2

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endocarditis, Thrombosis Trial in Paris (99mTc-Annexin V-128 SPECT)

Terminated
  • Endocarditis
  • Thrombosis
  • 99mTc-Annexin V-128 SPECT
  • Paris, France
    Bichat Hospital
Aug 25, 2021

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Rejection; Transplant, Liver, Liver Failure, Liver Diseases Trial in Cambridge, London (QEL-001)

Recruiting
  • Rejection; Transplant, Liver
  • +2 more
  • Birmingham, United Kingdom
  • +3 more
Dec 22, 2022

Tinnitus Trial in Dublin (PS1-PS4, PS6-PS10, PS7-PS4)

Completed
  • Tinnitus
  • PS1-PS4
  • +3 more
  • Dublin, Ireland
    St. James's Wellness Trust Clinical Research Facility
Sep 26, 2022

Ependymoma Trial in Pittsburgh (biological, drug, other)

Recruiting
  • Ependymoma
  • HLA-A2 restricted synthetic tumor antigen
  • +5 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
Oct 23, 2022

Lipoprotein-associated Phospholipase A2 in Type 2 Diabetes

Completed
Has Results
  • Type2 Diabetes
    • (no location specified)
    Apr 12, 2022

    Thromboxane A2 and Osteoarthritis

    Recruiting
    • Osteoarthritis
    • biological samples
    • NICE Cedex 1, France
      CHU de NICE
    Oct 20, 2022

    Healthy Volunteers Trial in Lille (Group (A1 ? A2), Group (A2 ? A1))

    Completed
    • Healthy Volunteers
    • Group (A1 → A2)
    • Group (A2 → A1)
    • Lille, Nord, France
      NutrInvest - Institut Pasteur de Lille
    Apr 5, 2022

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Milk Intolerance Trial in Turku (Dietary intervention)

    Recruiting
    • Milk Intolerance
    • Dietary intervention
    • Turku, Finland
      Food Chemistry and Food Development, Department of Life Technolo
    May 23, 2022

    Relapsed or Refractory Multiple Myeloma Trial in United States (CAR2 Anti-CD38 A2 CAR-T Cells)

    Completed
    • Relapsed or Refractory Multiple Myeloma
    • CAR2 Anti-CD38 A2 CAR-T Cells
    • Jacksonville, Florida
    • +3 more
    Mar 14, 2022

    Metastatic Triple-Negative Breast Carcinoma Trial (PVX-410)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • (no location specified)
    Apr 18, 2022

    CORONAVIRUS INFECTIONS Trial (anti-SARS-Cov-2 vaccination)

    Not yet recruiting
    • CORONAVIRUS INFECTIONS
    • anti-SARS-Cov-2 vaccination
    • (no location specified)
    Dec 15, 2022

    Multiple Myeloma Trial in Orange, Sacramento, Oklahoma City (STI-1492)

    Recruiting
    • Multiple Myeloma
    • STI-1492
    • Orange, California
    • +2 more
    Jan 12, 2023

    Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

    Recruiting
    • Endometrial Cancer
    • +8 more
    • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
    • Orlando, Florida
    • +21 more
    Feb 2, 2023

    T- and B-Cell Subpopulations in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 31, 2023

      Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

      Completed
      • Endometriosis
      • endometriosis surgery
      • other benign condition surgeries
      • Istanbul, Bagcilar, Turkey
        Bagcilar Teaching and Research Hospital
      Mar 26, 2022

      Autophagy/Apoptosis Balance During Pregnancy

      Recruiting
      • Pregnancy Related
      • Blood test
      • Nîmes, France
        CHU de Nimes
      Sep 20, 2022

      Tumors Trial in Worldwide (Letetresgene autoleucel)

      Active, not recruiting
      • Neoplasms
      • Letetresgene autoleucel
      • Pittsburgh, Pennsylvania
      • +5 more
      Aug 7, 2023

      Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

      Recruiting
      • Esophageal Cancer
      • Esophagogastric Junction Cancer
      • Autologous genetically modified ADP-A2M4CD8 cells
      • Duarte, California
      • +33 more
      Aug 23, 2022

      Platelet Aggregation, Spontaneous, Vascular Thrombosis Trial in Davis (Erythritol, Aspartame)

      Not yet recruiting
      • Platelet Aggregation, Spontaneous
      • Vascular Thrombosis
      • Erythritol
      • Aspartame
      • Davis, California
        Ragle Human Nutrition Research Center, University of California,
      Jul 21, 2023

      Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

      Completed
      • Advanced Renal Cell Carcinoma
      • Pazopanib + interferon alpha 2A
      • Hospitalet de Llobregat, Barcelona, Spain
      • +12 more
      Mar 9, 2022

      Oesophageal Adenocarcinoma, Squamous Cell Carcinoma, Solid Tumor Trial in United Kingdom (M6620, Cisplatin, Capecitabine)

      Completed
      • Oesophageal Adenocarcinoma
      • +2 more
      • Cardiff, United Kingdom
      • +4 more
      Apr 27, 2022

      Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

      Recruiting
      • Glioblastoma Multiforme of Brain
      • Multipeptide plus XS15
      • Tübingen, BW, Germany
        University Hospital Tübingen
      May 9, 2022

      Gestational Diabetes, Maternal Complication of Pregnancy Trial in New Haven (Continuous Glucose Monitor, Routine Care)

      Recruiting
      • Gestational Diabetes
      • Maternal Complication of Pregnancy
      • Continuous Glucose Monitor
      • Routine Care
      • New Haven, Connecticut
        Yale University
      Feb 1, 2022